December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
WOONSOCKET, R.I. — In becoming president of CVS/pharmacy, Helena Foulkes brings to the role a wealth of experience with diverse facets of the chain, especially health care offerings. Helena Foulkes Foulkes, 49, who succeeds Mark Cosby on January 1, has been CVS Caremark Corp.’s chief health care strategy and marketing officer, overseeing corporate strategy and
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
WASHINGTON — The importance of pharmacists to the success of the Affordable Care Act was reinforced late last month by National Association of Chain Drug Stores president and chief executive officer Steve Anderson. “Patients rely on their pharmacies as trusted sources of information on health care topics — even beyond medication issues,” Anderson said after
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
DEERFIELD, Ill. — The restructuring of Walgreen Co.’s management team continues. Under the leadership of Sona Chawla, the chain’s new Digital and Marketing Division will combine and integrate e-commerce, enterprisewide marketing, and customer loyalty and insights. Chawla will head the division in the newly created role of president of digital and chief marketing officer. She
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
CAMP HILL, Pa. — It’s evident that John Standley is confident in Rite Aid’s strategic game plan, which has reinvigorated the company financially and in the marketplace. When asked in an interview where Rite Aid goes from here, the chairman and chief executive officer said, “We stay focused on growing our business by meeting the
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
BENTONVILLE, Ark. — Walmart has named company veteran Doug McMillon to take over as president and chief executive officer after Mike Duke retires at the end of next month. He has also joined Walmart’s board of directors. “This leadership change comes at a time of strength and growth at Walmart,” chairman Rob Walton said after
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
WOONSOCKET, R.I. — CVS Caremark Corp. is buying Coram LLC from Apria Healthcare Group Inc. The $2.1 billion transaction — CVS Caremark’s largest deal in five years — was announced earlier this month. It will add specialty infusion services to the company’s offering. CVS executives say the acquisition won’t have a material impact on 2014
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
WASHINGTON — Pharmacy organizations have praised last month’s enactment of a federal comprehensive supply chain and compounding law. The Drug Quality and Security Act boosts the Food and Drug Administration’s authority to regulate compounding pharmacies that ship drugs across state lines. Its approval came a year after tainted injectable drugs from a Massachusetts compounding pharmacy
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
GREEN BAY, Wis. — Peter McMahon has been named chief executive officer of Shopko Stores Operating Co., replacing interim CEO Michael Bettiga. A 30-year retail veteran, McMahon most recently was chief operating officer of Loblaw Cos., Canada’s leading supermarket operator. Before joining Loblaws, McMahon held senior management positions with Walmart International in Germany and Japan
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
OTTAWA — Canada’s highest court dealt a blow to pharmacy chains earlier this month when it upheld Ontario’s ban on drug stores selling their own brands of private label generic drugs. In a 7-0 decision, justices of the Supreme Court of Canada said the province’s 2010 decision to outlaw the practice was consistent with its
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
EVANSTON, Ill. — Walgreen Co. has opened what it says is the nation’s first net-zero energy retail store. Anticipated to produce energy equal to or greater than it consumes, the new store here employs a pair of wind turbines, nearly 850 solar panels and a geothermal system burrowed 550 feet into the ground. Executives say
December 13, 2013 by Chain Drug Review
Issue 12-16-2013, News
REGINA, Saskatchewan — London Drugs opened a novel store here late last month. The company’s 78th unit, the 36,720-square-foot store is London Drugs’ second outlet in Regina and introduces a new open concept area where consumers’ technology needs can be addressed. The layout includes a 266-square-foot classroom-style learning lab where customers can consult with experts